Clinical Trials
21 trialsNCT06689800 2026-06-04
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Washington University School of Medicine
Phase NA Recruiting
NCT06839456 2026-04-15
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Phase 1/2 Recruiting
NCT02356653 2026-02-20
ExpMACs
Children's Hospital of Philadelphia
Phase EARLY_PHASE1 Recruiting
NCT01881334 2025-11-20
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Duke University
Available
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT03333486 2025-07-04
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Roswell Park Cancer Institute
Phase 2 Terminated
NCT03145545 2025-05-22
Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC
Children's Hospital of Philadelphia
Available
NCT02291965 2025-03-03
Blood Samples to Identify Biomarkers of Busulfan
Fred Hutchinson Cancer Center
Terminated
NCT06475469 2024-06-26
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
CHU de Reims
Phase NA Recruiting
NCT03609840 2023-09-21
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
University of California, San Francisco
Completed
NCT03373656 2022-07-26
Vaccination for Children of H&O and Their Parents
Children's Cancer Group, China
Phase NA Unknown
NCT00968864 2022-04-22
T-cell Depleted Alternative Donor Transplantation
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01316549 2021-10-04
HCT
University of California, San Francisco
Completed
NCT03609814 2021-10-04
Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
University of California, San Francisco
Completed
NCT03609827 2021-10-04
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
University of California, San Francisco
Completed
NCT01200017 2021-05-27
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
University of California, San Francisco
No longer available
NCT00801931 2019-03-27
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Columbia University
Phase 1/2 Terminated
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed
NCT00179790 2017-03-06
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Completed
NCT01050439 2015-04-15
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Columbia University
Phase 2 Terminated
NCT00001336 2008-03-04
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
National Institutes of Health Clinical Center (CC)
Completed